Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
A suggested positive control is rat lung tissue lysate.
PA5-34450 can be used with blocking peptide PEP-1492.
MYCT1 was initially identified as a novel target of the c-Myc oncogene in myeloid cells. It is a widely expressed nuclear protein whose overexpression can promote apoptosis, alteration of morphology, enhancement of anchorage-independent cell growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation. MYCT1 binds to the promoters of several c-Myc-regulated genes and it has been suggested that the phenotypes seen in MYCT1-overexpressing cells are a result of the deregulation of these genes. RUNX1-ETO, a fusion protein made up of RUNX1 and ETO, is thought to deregulate the proliferation and responsiveness of human hematopoietic progenitor cells downstream of MYCT1.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: MT-MC1; myc target in myeloid cells 1; Myc target in myeloid cells protein 1; Myc target protein 1
基因别名: 1110020B04Rik; AI225941; AI642973; MTLC; MTMC1; MYCT1
UniProt ID: (Human) Q8N699, (Mouse) Q8R411
Entrez Gene ID: (Human) 80177, (Mouse) 68632, (Rat) 292264